nitrates has been researched along with Cardiomyopathies, Primary in 24 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To specifically assess the synthetic activity of the L-arginine-NO metabolic pathway, urinary excretion of [15N]nitrates and [15N]urea was determined after a primed continuous intravenous infusion of L-[15N]arginine (40 micromol/kg) in 16 patients with congestive heart failure and 9 age-matched normal control subjects at rest and during submaximal treadmill exercise." | 7.70 | Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure. ( Katz, SD; Khan, T; Knecht, M; Mathew, L; Potharlanka, P; Whelan, J; Zeballos, GA, 1999) |
| "The changes in endothelium-derived vascular regulatory factors during dobutamine (DOB)-induced myocardial ischemia (MI) were investigated in 21 patients with Kawasaki disease aged from 11 months to 18 years." | 7.70 | Changes in endothelium-derived vascular regulatory factors during dobutamine-stress-induced silent myocardial ischemia in patients with Kawasaki disease. ( Hino, Y; Katsube, Y; Ogawa, S; Ohkubo, T, 1999) |
| " A few studies have reported arrhythmias or sudden deaths among workers exposed to solvents and organic nitrates." | 4.76 | Chemical exposures at work and cardiovascular morbidity. Atherosclerosis, ischemic heart disease, hypertension, cardiomyopathy and arrhythmias. ( Hietanen, E; Klockars, M; Kurppa, K; Partinen, M; Rantanen, J; Rönnemaa, T; Viikari, J, 1984) |
| "To examine the role of endothelin ETA and ETB receptors in congestive heart failure due to cardiomyopathy, the effect of chronic treatment with selective ETA- and ETB-receptor antagonists (atrasentan and A-192621, respectively), alone and in combination, was assessed on functional and biochemical parameters of 52-week-old Bio 14." | 3.74 | Nonselective ETA/ETB-receptor blockade increases systemic blood pressure of Bio 14.6 cardiomyopathic hamsters. ( Bkaily, G; Carrier, E; D'Orleans-Juste, P; Fecteau, MH; Honoré, JC; Tirapelli, CR, 2008) |
| "To specifically assess the synthetic activity of the L-arginine-NO metabolic pathway, urinary excretion of [15N]nitrates and [15N]urea was determined after a primed continuous intravenous infusion of L-[15N]arginine (40 micromol/kg) in 16 patients with congestive heart failure and 9 age-matched normal control subjects at rest and during submaximal treadmill exercise." | 3.70 | Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure. ( Katz, SD; Khan, T; Knecht, M; Mathew, L; Potharlanka, P; Whelan, J; Zeballos, GA, 1999) |
| "The changes in endothelium-derived vascular regulatory factors during dobutamine (DOB)-induced myocardial ischemia (MI) were investigated in 21 patients with Kawasaki disease aged from 11 months to 18 years." | 3.70 | Changes in endothelium-derived vascular regulatory factors during dobutamine-stress-induced silent myocardial ischemia in patients with Kawasaki disease. ( Hino, Y; Katsube, Y; Ogawa, S; Ohkubo, T, 1999) |
| "Daunorubicin is an anthracycline antitumour agent that can cause severe cardiomyopathy leading to a frequently fatal congestive heart failure." | 1.33 | Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats. ( Arafah, MM; Najjar, TA; Saad, SY, 2006) |
| "Liver cirrhosis is associated with enlarged right cardiac chambers." | 1.31 | Modification of cardiac function in cirrhotic patients with and without ascites. ( De Castro, S; Fiore, P; Funaro, S; Lionetti, R; Masini, A; Merli, M; Pulcinelli, G; Riggio, O; Valeriano, V, 2000) |
| "We hypothesize that the toxic radical peroxynitrite, arising from nitric oxide and superoxide anion, may be responsible for tetany and acute cardiomyocyte death." | 1.31 | UV light synergistically enhances the cardiotoxic effects of interleukin 1beta through peroxynitrite formation. ( Brooks, SS; Combes, A; Feldman, AM; McTiernan, C, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.83) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 10 (41.67) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neto-Neves, EM | 1 |
| Pinheiro, LC | 1 |
| Nogueira, RC | 1 |
| Portella, RL | 1 |
| Batista, RI | 1 |
| Tanus-Santos, JE | 2 |
| Honoré, JC | 1 |
| Carrier, E | 1 |
| Fecteau, MH | 1 |
| Tirapelli, CR | 1 |
| Bkaily, G | 1 |
| D'Orleans-Juste, P | 1 |
| Xi, L | 2 |
| Zhu, SG | 2 |
| Hobbs, DC | 1 |
| Kukreja, RC | 2 |
| Daiber, A | 1 |
| Gori, T | 1 |
| Münzel, T | 1 |
| Das, A | 1 |
| Chen, Q | 1 |
| Lesnefsky, EJ | 1 |
| van de Sandt, AM | 1 |
| Windler, R | 1 |
| Gödecke, A | 1 |
| Ohlig, J | 1 |
| Zander, S | 1 |
| Reinartz, M | 1 |
| Graf, J | 1 |
| van Faassen, EE | 1 |
| Rassaf, T | 1 |
| Schrader, J | 1 |
| Kelm, M | 1 |
| Merx, MW | 1 |
| Levine, TB | 1 |
| Levine, AB | 1 |
| Bolenbaugh, J | 1 |
| Green, PR | 1 |
| Tissier, S | 1 |
| Lancel, S | 1 |
| Marechal, X | 1 |
| Mordon, S | 1 |
| Depontieu, F | 1 |
| Scherpereel, A | 1 |
| Chopin, C | 1 |
| Neviere, R | 1 |
| Heper, G | 1 |
| Kose, S | 1 |
| Cai, L | 1 |
| Saad, SY | 1 |
| Najjar, TA | 1 |
| Arafah, MM | 1 |
| Pflederer, W | 1 |
| Kurppa, K | 1 |
| Hietanen, E | 1 |
| Klockars, M | 1 |
| Partinen, M | 1 |
| Rantanen, J | 1 |
| Rönnemaa, T | 1 |
| Viikari, J | 1 |
| Serbin, VI | 1 |
| Gasanova, AS | 1 |
| Grunwald, JE | 1 |
| DuPont, J | 1 |
| Dreyer, EB | 1 |
| Drance, SM | 1 |
| Katz, SD | 1 |
| Khan, T | 1 |
| Zeballos, GA | 1 |
| Mathew, L | 1 |
| Potharlanka, P | 1 |
| Knecht, M | 1 |
| Whelan, J | 1 |
| Hino, Y | 1 |
| Ohkubo, T | 1 |
| Katsube, Y | 1 |
| Ogawa, S | 1 |
| Liu, H | 1 |
| Ma, Z | 1 |
| Lee, SS | 1 |
| Valeriano, V | 1 |
| Funaro, S | 1 |
| Lionetti, R | 1 |
| Riggio, O | 1 |
| Pulcinelli, G | 1 |
| Fiore, P | 1 |
| Masini, A | 1 |
| De Castro, S | 1 |
| Merli, M | 1 |
| Combes, A | 1 |
| McTiernan, C | 1 |
| Brooks, SS | 1 |
| Feldman, AM | 1 |
| Coelho-Filho, OR | 1 |
| De Luca, IM | 1 |
| Cittadino, M | 1 |
| Sampaio, RC | 1 |
| Coelho, OR | 1 |
| Hyslop, S | 1 |
| Moreno Júnior, H | 1 |
| Lin, JH | 1 |
| Duffy, JL | 1 |
| Scriabine, A | 1 |
| Stebbins, RB | 1 |
3 reviews available for nitrates and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy.
Topics: Cardiomyopathies; Diabetes Mellitus; Diabetic Angiopathies; Humans; Metallothionein; Nitrates; Nitro | 2006 |
Chemical exposures at work and cardiovascular morbidity. Atherosclerosis, ischemic heart disease, hypertension, cardiomyopathy and arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Arsenic; Arteriosclerosis; Cadmium; Carbon Disulfide; Carbon Monoxide | 1984 |
[Peripheral vasodilators in the treatment of heart failure].
Topics: Cardiac Output; Cardiomyopathies; Coronary Circulation; Droperidol; Heart Failure; Humans; Hydralazi | 1982 |
1 trial available for nitrates and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Effect of chronic nitrate treatment on retinal vessel caliber in open-angle glaucoma.
Topics: Aged; Blood Flow Velocity; Cardiomyopathies; Disease Progression; Exfoliation Syndrome; Female; Glau | 1997 |
20 other studies available for nitrates and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Sodium nitrite improves hypertension-induced myocardial dysfunction by mechanisms involving cardiac S-nitrosylation.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomyopathies; Heart; Hypertension; Male; Myoca | 2019 |
Nonselective ETA/ETB-receptor blockade increases systemic blood pressure of Bio 14.6 cardiomyopathic hamsters.
Topics: Animals; Atrasentan; Blood Pressure; Cardiomyopathies; Cricetinae; Endothelin A Receptor Antagonists | 2008 |
Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Cardiomyopathies; Cardiotonic Agents; Cardiotoxi | 2011 |
Inorganic nitrate therapy improves Doxorubicin-induced cardiomyopathy a new window for an affordable cardiovascular therapy for everyone?
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Dietary Supplements; Doxorubicin; Humans; Mi | 2011 |
Dietary nitrate supplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Dietary Supplements; Doxorubicin; Electron T | 2011 |
Endothelial NOS (NOS3) impairs myocardial function in developing sepsis.
Topics: Animals; Arterial Pressure; Cardiac Output; Cardiomyopathies; Coronary Circulation; Disease Models, | 2013 |
Reversal of heart failure remodeling: is it maintained?
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Cardiomyopathies; Echocardiography; Female | 2003 |
Calpain inhibitors improve myocardial dysfunction and inflammation induced by endotoxin in rats.
Topics: Animals; Cardiomyopathies; Endotoxins; Glycoproteins; Heart; In Vitro Techniques; Inflammation; Inje | 2004 |
Increased myocardial ischemia during nitrate therapy: caused by multiple coronary artery-left ventricle fistulae?
Topics: Cardiomyopathies; Coronary Disease; Fistula; Heart Ventricles; Humans; Male; Middle Aged; Myocardial | 2005 |
Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Aspartate Aminotransferases; Azoles; Cardiomyopa | 2006 |
[Therapy of cardiomyopathies].
Topics: Adrenergic beta-Agonists; Anti-Arrhythmia Agents; Anticoagulants; Captopril; Cardiac Glycosides; Car | 1982 |
Glaucoma: a look beyond intraocular pressure.
Topics: Blood Flow Velocity; Cardiomyopathies; Glaucoma, Open-Angle; Humans; Nitrates; Retinal Vessels; Vaso | 1997 |
Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure.
Topics: Adult; Aged; Arginine; Cardiomyopathies; Creatinine; Exercise Test; Female; Heart Failure; Humans; L | 1999 |
Changes in endothelium-derived vascular regulatory factors during dobutamine-stress-induced silent myocardial ischemia in patients with Kawasaki disease.
Topics: Adolescent; Calcinosis; Cardiomyopathies; Child; Child, Preschool; Coronary Angiography; Dobutamine; | 1999 |
Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
Topics: Animals; Bile Ducts; Blotting, Western; Cardiomyopathies; Constriction, Pathologic; Cyclic GMP; Cyto | 2000 |
Modification of cardiac function in cirrhotic patients with and without ascites.
Topics: Ascites; Cardiomyopathies; Case-Control Studies; Echocardiography; Echocardiography, Doppler, Color; | 2000 |
UV light synergistically enhances the cardiotoxic effects of interleukin 1beta through peroxynitrite formation.
Topics: Animals; Animals, Newborn; Cardiomyopathies; Drug Synergism; Homeostasis; In Vitro Techniques; Inter | 2001 |
Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats.
Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Cardiomyopathies; Disease Models, Animal; E | 2001 |
Cobalt-induced myocardial lesions in rats.
Topics: Animals; Cardiomyopathies; Cobalt; Mitochondria; Myocardium; Myofibrils; Nitrates; Rats; Time Factor | 1970 |
Protection of rats from isoproterenol induced myocardial necrosis by trolnitrate phosphate (Metamine).
Topics: Animals; Cardiomyopathies; Drug Antagonism; Isoproterenol; Necrosis; Nitrates; Rats; Vasodilator Age | 1966 |